| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pantothenate kinase activity | 3.93e-06 | 4 | 200 | 3 | GO:0004594 | |
| GeneOntologyMolecularFunction | cyclosporin A binding | 8.87e-05 | 24 | 200 | 4 | GO:0016018 | |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 9.98e-05 | 2 | 200 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 9.98e-05 | 2 | 200 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 3.32e-04 | 14 | 200 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 4.47e-04 | 136 | 200 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.88e-04 | 227 | 200 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | acetyl-CoA binding | 5.91e-04 | 4 | 200 | 2 | GO:1905502 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SYNPO2 PDE4B MYO7A STRBP SPTA1 SPTBN1 DLGAP5 CLASP2 JAKMIP2 JMY DLC1 FES VIL1 DIP2B NRCAM CORO2A SYNE1 DNM1L FARP1 MACF1 MYH15 SNTB2 MYBPC3 | 6.73e-04 | 1099 | 200 | 23 | GO:0008092 |
| GeneOntologyBiologicalProcess | organelle assembly | RPL10L SYNPO2 MYO7A USP9X DLGAP5 CLASP2 WDR54 CNOT6 TBC1D32 MDN1 TBC1D1 IFT80 YTHDF2 DYNC1H1 WNK3 VIL1 EFL1 B3GLCT ATG7 SYNE1 SPG11 RFX4 CNOT6L CCDC42 TPX2 TNKS SPAG17 RPL10 AURKB MYBPC3 | 4.20e-07 | 1138 | 197 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | RPL10L DLGAP5 CLASP2 CNOT6 MDN1 YTHDF2 DYNC1H1 WNK3 VIL1 EFL1 CNOT6L TPX2 TNKS RPL10 AURKB MYBPC3 | 1.41e-05 | 475 | 197 | 16 | GO:0140694 |
| GeneOntologyBiologicalProcess | endocytosis | MYO7A WDR54 FCER2 FCGR1A FCGR1BP SYNJ2 PIK3CG RNF216 VAV2 DOCK2 AMPH DNAJC13 ANKFY1 ATG7 SYNE1 DNM1L SPG11 RUFY1 RUFY2 MTMR6 SCARB1 SORL1 | 1.46e-05 | 827 | 197 | 22 | GO:0006897 |
| GeneOntologyBiologicalProcess | early endosome to recycling endosome transport | 2.92e-05 | 7 | 197 | 3 | GO:0061502 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | CLASP2 WDR54 FCGR1A FCGR1BP FES RNF216 DOCK2 AMPH DNAJC13 ANKFY1 ATG7 SYNE1 DNM1L RUFY1 RUFY2 SCARB1 DYNC1LI1 SORL1 | 7.61e-05 | 667 | 197 | 18 | GO:0060627 |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of cardiac muscle | 9.08e-05 | 2 | 197 | 2 | GO:1901898 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | WDR54 FCGR1A FCGR1BP RNF216 DOCK2 AMPH ANKFY1 ATG7 SYNE1 DNM1L RUFY1 RUFY2 SCARB1 | 9.90e-05 | 389 | 197 | 13 | GO:0030100 |
| GeneOntologyBiologicalProcess | positive regulation of monooxygenase activity | 1.19e-04 | 27 | 197 | 4 | GO:0032770 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 1.20e-04 | 115 | 197 | 7 | GO:0018107 | |
| Domain | Type_II_PanK | 4.80e-06 | 4 | 200 | 3 | IPR004567 | |
| Domain | Fumble | 4.80e-06 | 4 | 200 | 3 | PF03630 | |
| Domain | PH_dom-like | DAB2IP MYO7A SPTBN1 TBC1D1 OSBPL8 HOMER1 VAV2 ARHGAP10 WDFY4 CDC42BPB RGS3 MTMR6 FARP1 SBF2 SPRED1 SNTB2 | 1.49e-05 | 426 | 200 | 16 | IPR011993 |
| Domain | - | DAB2IP MYO7A SPTBN1 TBC1D1 OSBPL8 HOMER1 VAV2 ARHGAP10 CDC42BPB RGS3 MTMR6 FARP1 SBF2 SPRED1 | 8.58e-05 | 391 | 200 | 14 | 2.30.29.30 |
| Domain | Spectrin | 9.63e-05 | 23 | 200 | 4 | PF00435 | |
| Domain | Ribosomal_L10e_CS | 1.14e-04 | 2 | 200 | 2 | IPR018255 | |
| Domain | Ribosomal_L10e | 1.14e-04 | 2 | 200 | 2 | IPR001197 | |
| Domain | RIBOSOMAL_L10E | 1.14e-04 | 2 | 200 | 2 | PS01257 | |
| Domain | - | 1.59e-04 | 26 | 200 | 4 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 1.59e-04 | 26 | 200 | 4 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 1.85e-04 | 27 | 200 | 4 | IPR005135 | |
| Domain | Spectrin_repeat | 2.46e-04 | 29 | 200 | 4 | IPR002017 | |
| Domain | Ribosomal_L10e/L16 | 3.40e-04 | 3 | 200 | 2 | IPR016180 | |
| Domain | - | 3.40e-04 | 3 | 200 | 2 | 3.90.1170.10 | |
| Domain | Ribosomal_L16 | 3.40e-04 | 3 | 200 | 2 | PF00252 | |
| Domain | SPEC | 3.63e-04 | 32 | 200 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.63e-04 | 32 | 200 | 4 | IPR018159 | |
| Domain | ATPase_dyneun-rel_AAA | 4.04e-04 | 14 | 200 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.04e-04 | 14 | 200 | 3 | PF07728 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 2.58e-05 | 53 | 157 | 6 | M662 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 4.59e-05 | 7 | 157 | 3 | M27087 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 4.59e-05 | 7 | 157 | 3 | MM14765 | |
| Pubmed | DAB2IP DLGAP2 PDE4B USP9X SPTBN1 SENP3 DLGAP5 RIPK2 CLASP2 JAKMIP2 MDN1 FAM120A HOMER1 DYNC1H1 WNK3 DIP2B DNAJC13 ANKFY1 NRCAM SYNE1 DNM1L PEX5L CDC42BPB FARP1 MACF1 TNKS TAF15 LGI1 | 3.54e-12 | 963 | 204 | 28 | 28671696 | |
| Pubmed | DLGAP2 PDE4D MYO7A USP9X SPTA1 SPTBN1 PSMD2 CLASP2 JMY NWD2 FAM120A FCGR1A FCGR1BP OSBPL8 HOMER1 DYNC1H1 DPP6 AMPH DNAJC13 NRCAM CORO2A SYNE1 DNM1L CDC42BPB SRRT RNPEP SUGP2 FARP1 MACF1 TAF15 RPL10 LGI1 TPI1 | 1.79e-11 | 1431 | 204 | 33 | 37142655 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP DLGAP2 PDE4D USP9X SPTBN1 NMRAL1 HOMER1 DYNC1H1 AMPH NRCAM SYNE1 DNM1L DYNC1LI1 MACF1 | 1.46e-09 | 281 | 204 | 14 | 28706196 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE4D ERV3-1 ASH1L CLASP2 FAM120A SYNJ2 TBC1D1 SLX4IP NTN1 VAV2 NOTCH3 DIP2B DPP6 GALNT10 DNAJC13 SLC16A9 ATG7 ARHGAP10 CDC42BPB CCND3 SUGP2 FARP1 SCARB1 SBF2 SETBP1 DIP2C MACF1 EIF2AK4 KDM4B DOP1A | 3.87e-09 | 1489 | 204 | 30 | 28611215 |
| Pubmed | DAB2IP USP34 KDM3B TBC1D1 OSBPL8 ANKFY1 SYNE1 CDC42BPB SETBP1 DIP2C MACF1 KDM4B | 1.05e-08 | 225 | 204 | 12 | 12168954 | |
| Pubmed | HSP90AB4P STRBP DLGAP5 KDM3B PSMD2 NDUFA10 NSD3 CNOT6 FAM120A DNAJC10 OSBPL8 PLOD2 QSOX2 YTHDF2 DYNC1H1 NPR3 DNAJC13 DNM1L CDC42BPB MTMR6 RNPEP SCARB1 TPX2 MACF1 RPL10 AURKB | 5.19e-08 | 1297 | 204 | 26 | 33545068 | |
| Pubmed | USP34 STRBP USP9X SPTBN1 PSMD2 MDN1 FAM120A OSBPL8 DYNC1H1 EXOSC10 NUP107 RRP1 RNPEP SUGP2 GEMIN4 MACF1 TAF15 RPL10 | 7.06e-08 | 653 | 204 | 18 | 22586326 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DTD1 PPP2R2D STRBP USP9X SPTBN1 CLASP2 NWD2 FAM120A DNAJC10 DIP2B EXOSC10 SRRT DYNC1LI1 TNKS RPL10 | 1.63e-07 | 475 | 204 | 15 | 31040226 |
| Pubmed | USP34 ATP7A SENP3 KDM3B CLASP2 DYNC1H1 FAT4 EXOSC10 DNAJC13 NUP107 DNM1L RUFY1 CDC42BPB LRIG3 SUGP2 SLFN13 TAF15 RPL10 TPI1 | 1.92e-07 | 777 | 204 | 19 | 35844135 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 17379144 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 17631502 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 23152917 | ||
| Pubmed | HSP90AB4P USP9X SPTBN1 PSMD2 CLASP2 MDN1 DNAJC10 DYNC1H1 EXOSC10 DNAJC13 ANKFY1 NUP107 DNM1L SUGP2 GEMIN4 DYNC1LI1 RPL10 | 2.66e-07 | 638 | 204 | 17 | 33239621 | |
| Pubmed | DAB2IP DLGAP2 PDE4B SPTBN1 HOMER1 DYNC1H1 DIP2B SYNE1 FARP1 MACF1 LGI1 | 3.17e-07 | 251 | 204 | 11 | 27507650 | |
| Pubmed | RPL10L ATP7A USP9X INPP5K PSMD2 CLASP2 CNOT6 MDN1 FAM120A DNAJC10 PIK3CG OSBPL8 ITPRIPL1 DYNC1H1 DOCK2 DIP2B EXOSC10 DNAJC13 NUP107 DNM1L GEMIN4 DYNC1LI1 RPL10 | 4.43e-07 | 1168 | 204 | 23 | 19946888 | |
| Pubmed | DAB2IP USP34 PDE4B SPTBN1 DLGAP5 ASH1L CLASP2 ACVR2A GBP4 QSOX2 EXOSC10 PANK3 DNM1L WDFY4 MTMR6 CNOT6L FARP1 SBF2 LTN1 MACF1 SPRED1 EIF2AK4 | 4.86e-07 | 1084 | 204 | 22 | 11544199 | |
| Pubmed | FAM120A YTHDF2 DYNC1H1 EXOSC10 DNAJC13 NUP107 DNM1L CDC42BPB RRP1 RUFY2 SUGP2 SBF2 MACF1 EIF2AK4 SNTB2 RPL10 | 6.12e-07 | 601 | 204 | 16 | 33658012 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 22815849 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 2981478 | ||
| Pubmed | A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. | 7.92e-07 | 4 | 204 | 3 | 11479594 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPTBN1 RIPK2 KDM3B CLASP2 NSD3 PANK2 DLC1 MDN1 SYNJ2 TBC1D1 OSBPL8 YTHDF2 WNK3 DIP2B PANK3 DNM1L SRRT MACF1 DOP1A | 9.00e-07 | 861 | 204 | 19 | 36931259 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 HSP90AB4P USP9X CLASP2 ACVR2A NDUFA10 MDN1 ODR4 GNAL QSOX2 NOTCH3 GALNT10 IL31RA SPG11 RUFY2 LRIG3 RNPEP SCARB1 LTN1 DYNC1LI1 MACF1 | 1.34e-06 | 1061 | 204 | 21 | 33845483 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MYO7A USP9X SPTBN1 RIPK2 CLASP2 MDN1 DNAJC10 OSBPL8 HOMER1 SPG11 RUFY1 RPIA EIF2AK4 KDM4B | 1.64e-06 | 497 | 204 | 14 | 36774506 |
| Pubmed | DAB2IP DLGAP2 USP9X SPTA1 NWD2 HOMER1 CORO2A DNM1L CDC42BPB ELFN1 FARP1 DYNC1LI1 MACF1 | 1.80e-06 | 430 | 204 | 13 | 32581705 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SPTBN1 SENP3 PSMD2 MDN1 DYNC1H1 DOCK2 EXOSC10 DNAJC13 NUP107 DNM1L TPX2 GEMIN4 DYNC1LI1 MACF1 AURKB | 2.07e-06 | 582 | 204 | 15 | 20467437 |
| Pubmed | 2.48e-06 | 102 | 204 | 7 | 11214970 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | USP9X SPTBN1 MDN1 DYNC1H1 DIP2B EXOSC10 NUP107 DNM1L SRRT TPX2 RPL10 | 4.81e-06 | 332 | 204 | 11 | 32786267 |
| Pubmed | SPTBN1 KDM3B PSMD2 MDN1 DNAJC10 OSBPL8 DYNC1H1 NUP107 RGS3 TPI1 | 5.28e-06 | 272 | 204 | 10 | 31010829 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 PPP2R2D PSMD2 FAM120A DNAJC10 OSBPL8 QSOX2 DIP2B EXOSC10 ARHGAP10 DNM1L MTMR6 WDR97 LTN1 GEMIN4 TNKS SNTB2 RPL10 SORL1 | 5.38e-06 | 974 | 204 | 19 | 28675297 |
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 22905218 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 7.28e-06 | 168 | 204 | 8 | 30631154 | |
| Pubmed | USP34 DLGAP5 KDM3B CLASP2 FAM120A SYNJ2 OSBPL8 YTHDF2 ITPRIPL1 TANK RADX SPG11 MTMR6 CNOT6L TPX2 DYNC1LI1 | 7.75e-06 | 733 | 204 | 16 | 34672954 | |
| Pubmed | STRBP SENP3 KDM3B FAM120A DNAJC10 RNF216 QSOX2 YTHDF2 DIP2B RGS3 CEMIP SRRT EIF2AK4 HSD17B11 SORL1 | 7.81e-06 | 650 | 204 | 15 | 38777146 | |
| Pubmed | FAM120A OSBPL8 ZNF616 DOCK2 GBA2 WDFY4 CDC42BPB RUFY2 SBF2 LTN1 DIP2C MACF1 DOP1A | 7.90e-06 | 493 | 204 | 13 | 15368895 | |
| Pubmed | RPP40 SENP3 CLASP2 NDUFA10 NSD3 CNOT6 MDN1 OSBPL8 KDM2B TBX2 ARHGAP10 SYNE1 CDC42BPB RRP1 SRRT CNOT6L FARP1 TPX2 LTN1 GEMIN4 MACF1 TAF15 SNTB2 RPL10 | 8.57e-06 | 1497 | 204 | 24 | 31527615 | |
| Pubmed | SPTBN1 CLASP2 FAM120A VAV2 NOTCH3 EXOSC10 ANKFY1 SYNE1 LAMA4 CDC42BPB MACF1 SPRED1 TNKS | 8.61e-06 | 497 | 204 | 13 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | USP9X FABP7 OSBPL8 GNAL DIP2B NUP107 CDC42BPB SUGP2 FARP1 GEMIN4 DYNC1LI1 MACF1 RPL10 | 8.79e-06 | 498 | 204 | 13 | 36634849 |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 24659802 | ||
| Pubmed | Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines. | 1.09e-05 | 8 | 204 | 3 | 23744294 | |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 22138510 | ||
| Pubmed | 1.12e-05 | 128 | 204 | 7 | 30995482 | ||
| Pubmed | 1.13e-05 | 85 | 204 | 6 | 23055939 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | STRBP SENP3 MDN1 FAM120A DNAJC10 YTHDF2 EXOSC10 DNAJC13 RADX RRP1 SRRT SUGP2 TPX2 MACF1 RPL10 AURKB | 1.19e-05 | 759 | 204 | 16 | 35915203 |
| Pubmed | DAB2IP DLGAP2 USP9X SPTBN1 PSMD2 NDUFA10 FABP7 OSBPL8 ALDH6A1 HOMER1 AMPH NRCAM CDC42BPB SUGP2 ELFN1 FARP1 DYNC1LI1 MACF1 RPL10 TPI1 | 1.40e-05 | 1139 | 204 | 20 | 36417873 | |
| Pubmed | DAB2IP PPP2R2D USP9X SPTBN1 PSMD2 CLASP2 NSD3 EFL1 DNAJC13 NUP107 ARHGAP10 CDC42BPB MTMR6 FARP1 SBF2 LTN1 EIF2AK4 SNTB2 AURKB | 1.52e-05 | 1049 | 204 | 19 | 27880917 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSP90AB4P USP9X SPTBN1 PSMD2 CLASP2 MDN1 FAM120A PLOD2 HOMER1 YTHDF2 DYNC1H1 EXOSC10 CORO2A DNM1L RNPEP GEMIN4 DYNC1LI1 MACF1 RPL10 TPI1 | 1.59e-05 | 1149 | 204 | 20 | 35446349 |
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 23150715 | ||
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 24155889 | ||
| Pubmed | USP34 PPP2R2D DLGAP5 KDM3B CNOT6 SYNJ2 KDM2B IFT80 SPG11 LRIG3 SETBP1 EIF2AK4 KDM4B | 1.66e-05 | 529 | 204 | 13 | 14621295 | |
| Pubmed | DTD1 STRBP SPTBN1 CLASP2 NDUFA10 FAM120A OSBPL8 PLOD2 YTHDF2 DYNC1H1 VIL1 EXOSC10 CDC42BPB RRP1 SRRT SUGP2 FARP1 TPX2 GEMIN4 TAF15 EIF2AK4 TPI1 | 2.06e-05 | 1371 | 204 | 22 | 36244648 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | FAM120A FCGR1A FCGR1BP YTHDF2 DIP2B TFEC TCN2 SYNE1 FARP1 RPL10 | 2.22e-05 | 321 | 204 | 10 | 32098917 |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 18949059 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 10614646 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 7698769 | ||
| Pubmed | USP34 USP9X SPTBN1 ASH1L PSMD2 NDUFA10 RXRG FAM120A FCGR1A OSBPL8 RNF216 DYNC1H1 NRCAM CORO2A SYNE1 CDC42BPB RUFY2 MACF1 SPRED1 TNKS LGI1 | 2.46e-05 | 1285 | 204 | 21 | 35914814 | |
| Pubmed | USP9X SPTBN1 PSMD2 CLASP2 FAM120A ODR4 YTHDF2 EXOSC10 ANKFY1 SRRT GEMIN4 TAF15 TPI1 | 2.54e-05 | 551 | 204 | 13 | 34728620 | |
| Pubmed | SPTBN1 SENP3 PSMD2 MDN1 FAM120A DNAJC10 DYNC1H1 EXOSC10 DNM1L CDC42BPB SRRT GEMIN4 DYNC1LI1 TAF15 RPL10 TPI1 | 2.58e-05 | 809 | 204 | 16 | 32129710 | |
| Pubmed | 2.74e-05 | 147 | 204 | 7 | 16959763 | ||
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 21248252 | ||
| Pubmed | DAB2IP TBC1D1 HERC3 DYNC1H1 ANKFY1 NRCAM SYNE1 VPS8 LRIG3 SUGP2 MACF1 | 3.18e-05 | 407 | 204 | 11 | 12693553 | |
| Pubmed | 3.37e-05 | 103 | 204 | 6 | 10574462 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 3.42e-05 | 2 | 204 | 2 | 37733444 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 31324945 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28607113 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 9257847 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28235598 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25882071 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25231998 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 30190171 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 34788619 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 3.42e-05 | 2 | 204 | 2 | 2136886 | |
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 3.42e-05 | 2 | 204 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 3.42e-05 | 2 | 204 | 2 | 35833115 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 3.42e-05 | 2 | 204 | 2 | 15528358 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 3.42e-05 | 2 | 204 | 2 | 14991835 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1402657 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 3.42e-05 | 2 | 204 | 2 | 10752630 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 31211699 | ||
| Pubmed | PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts. | 3.42e-05 | 2 | 204 | 2 | 21288894 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 16849450 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 38524127 | ||
| Pubmed | Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4. | 3.42e-05 | 2 | 204 | 2 | 29123207 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8077658 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15357953 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 35987690 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 3.42e-05 | 2 | 204 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 3.42e-05 | 2 | 204 | 2 | 16305642 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 21124939 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 3.42e-05 | 2 | 204 | 2 | 24430180 | |
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 3.42e-05 | 2 | 204 | 2 | 38885133 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 3.42e-05 | 2 | 204 | 2 | 1430234 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15835266 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 17325199 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8663283 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1830050 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15003452 | ||
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 3.42e-05 | 2 | 204 | 2 | 21325219 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8611682 | ||
| Interaction | KCTD13 interactions | DLGAP2 PDE4D MYO7A USP9X SPTA1 SPTBN1 PSMD2 CLASP2 JMY FABP7 NWD2 FAM120A FCGR1A OSBPL8 HOMER1 DYNC1H1 DPP6 AMPH DNAJC13 NRCAM CORO2A SYNE1 DNM1L CDC42BPB SRRT RNPEP SUGP2 FARP1 MACF1 TAF15 RPL10 LGI1 TPI1 | 3.38e-06 | 1394 | 202 | 33 | int:KCTD13 |
| Interaction | AGAP2 interactions | DAB2IP DLGAP2 USP9X SPTBN1 NMRAL1 HOMER1 DYNC1H1 NRCAM SYNE1 DYNC1LI1 MACF1 | 9.26e-06 | 210 | 202 | 11 | int:AGAP2 |
| Interaction | DLGAP1 interactions | DAB2IP DLGAP2 PDE4B USP9X SPTBN1 DLGAP5 HOMER1 SYNE1 FARP1 LGI1 | 1.43e-05 | 180 | 202 | 10 | int:DLGAP1 |
| GeneFamily | Regulators of G-protein signaling | 4.70e-04 | 21 | 133 | 3 | 720 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 7.03e-04 | 24 | 133 | 3 | 485 | |
| GeneFamily | Fibrinogen C domain containing | 7.95e-04 | 25 | 133 | 3 | 554 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.10e-03 | 7 | 133 | 2 | 1113 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.50e-03 | 31 | 133 | 3 | 81 | |
| GeneFamily | Phosphoinositide phosphatases | 1.65e-03 | 32 | 133 | 3 | 1079 | |
| GeneFamily | CCR4-NOT transcription complex | 2.83e-03 | 11 | 133 | 2 | 1023 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GALNT15 SYCP2L PDE4D MYO7A ACVR2A TBC1D32 MDN1 KDM2B GNAL VAV2 WNK3 DIP2B DPP6 SLC16A9 PEX5L CEMIP RUFY2 MTMR6 CNOT6L SUGP2 WDR97 ASXL3 SBF2 TNKS SPAG17 DOP1A | 4.45e-07 | 1106 | 202 | 26 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 USP9X DLGAP5 KDM3B CLASP2 DLC1 MDN1 SYNJ2 OSBPL8 PLOD2 HOMER1 AMPH DNAJC13 TANK SPG11 CEMIP LTN1 MACF1 TNKS TAF15 MYBL1 | 3.21e-06 | 856 | 202 | 21 | M4500 |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN | FGL2 FCGR1BP TBC1D1 DOCK2 DNAJC13 HSD17B11 SNTB2 RPL10 SORL1 TPI1 | 3.57e-06 | 199 | 202 | 10 | M9913 |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | ARMC3 PPP2R2D STRBP NSD3 PIK3CG TBC1D1 NSMCE1 CCND3 ELFN1 TPX2 | 3.57e-06 | 199 | 202 | 10 | M7524 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | RPL10L PDE4D USP9X RPP40 INPP5K NSD3 MID1IP1 DNAJC10 FCGR1A IFT80 ALDH6A1 HOMER1 TFEC B3GLCT TANK VPS8 SPG11 MTMR6 SLFN13 SCARB1 TAF15 | 1.37e-05 | 942 | 202 | 21 | M8144 |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.36e-05 | 197 | 202 | 9 | M5480 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | SPTBN1 DLGAP5 MID1IP1 DYNC1H1 DOCK2 ARHGAP10 FARP1 TPX2 GEMIN4 | 2.55e-05 | 199 | 202 | 9 | M5893 |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP | 2.66e-05 | 200 | 202 | 9 | M7515 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 3.25e-05 | 158 | 202 | 8 | M372 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 3.30e-06 | 67 | 201 | 7 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 2.81e-05 | 206 | 201 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | HLA-DPA1 STRBP DNAJC10 FCER2 VAV2 WDFY4 GDF7 IGHD SETBP1 KDM4B | 2.35e-08 | 194 | 204 | 10 | ff661419b697aef51a53fdeac8d37d870d65f491 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-07 | 184 | 204 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-07 | 184 | 204 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-07 | 184 | 204 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.93e-07 | 194 | 204 | 9 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 197 | 204 | 9 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 197 | 204 | 9 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | NS-moderate-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | PDE4B HLA-DPA1 JAKMIP2 FCGR1A FCGR1BP PIK3CG TFEC WDFY4 RGS18 | 3.48e-07 | 198 | 204 | 9 | 1791f1b1195ac1735ca2c1e6adf04a7f39d63ac1 |
| ToppCell | Mild/Remission-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.63e-07 | 199 | 204 | 9 | 0451b1536be3725a520bfdd2b3dff133bea812e8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-06 | 168 | 204 | 8 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-06 | 175 | 204 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-06 | 175 | 204 | 8 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.79e-06 | 179 | 204 | 8 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-06 | 182 | 204 | 8 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.11e-06 | 183 | 204 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.11e-06 | 183 | 204 | 8 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 184 | 204 | 8 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-06 | 186 | 204 | 8 | 6575ec6a626cdea169ffd185d47828dfaa29475d | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.48e-06 | 187 | 204 | 8 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.48e-06 | 187 | 204 | 8 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 190 | 204 | 8 | 5e0e4a48159ec05ba1b599752b769a7b4da08588 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-06 | 191 | 204 | 8 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.02e-06 | 192 | 204 | 8 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 3.02e-06 | 192 | 204 | 8 | e54577183b09599a3b2bdd532a18ea8f4a6e3524 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 192 | 204 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.02e-06 | 192 | 204 | 8 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.02e-06 | 192 | 204 | 8 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.13e-06 | 193 | 204 | 8 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.13e-06 | 193 | 204 | 8 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 193 | 204 | 8 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.13e-06 | 193 | 204 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 193 | 204 | 8 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 3.13e-06 | 193 | 204 | 8 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.26e-06 | 194 | 204 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 195 | 204 | 8 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.38e-06 | 195 | 204 | 8 | a045fb8a377e54fb57fef1181d4c3fc15d627ef6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.38e-06 | 195 | 204 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 196 | 204 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.51e-06 | 196 | 204 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.51e-06 | 196 | 204 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.51e-06 | 196 | 204 | 8 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 197 | 204 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 197 | 204 | 8 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.65e-06 | 197 | 204 | 8 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | NS-control-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-06 | 198 | 204 | 8 | 846852943a8ff60f746fd49498240e25ca1c1b09 | |
| ToppCell | Bronchial_Biopsy-Immune|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.79e-06 | 198 | 204 | 8 | 1c30eebbe16a331039a9063b93774b5daf518b6e | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 198 | 204 | 8 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 198 | 204 | 8 | fa5c15a656d4132950092919600e270f1fd79abf | |
| ToppCell | BLOOD--(3)_MNP-(3)_Intermediate_monocytes|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.79e-06 | 198 | 204 | 8 | 70c3efd4f6026a6a6065be632160a265d9ecd1e4 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | mLN-(2)_B_cell|mLN / shred on region, Cell_type, and subtype | 3.93e-06 | 199 | 204 | 8 | 9464c8c72a6b2e14a27b413cc1f5d64550212776 | |
| ToppCell | Mild/Remission-B_naive-9|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.93e-06 | 199 | 204 | 8 | e9af3c6a05f435ac8d7066f54feb653012b51ffb | |
| ToppCell | mLN-B_cell|mLN / Region, Cell class and subclass | 3.93e-06 | 199 | 204 | 8 | 99c7d157a1e819ff86c526ffd9b7036ed3514cae | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | 5abfbccae147d399e4234f90ae5cd9529abe4dd1 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 1438b84096de9b4abe9e6213caa07f6bdff67358 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mLN-B_cell-Follicular_B_cell|B_cell / Region, Cell class and subclass | 4.08e-06 | 200 | 204 | 8 | 8fbd27ffcfd0702ad3c340d32455e36a01617139 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.08e-06 | 200 | 204 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.29e-06 | 147 | 204 | 7 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.00e-05 | 162 | 204 | 7 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 164 | 204 | 7 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 113 | 204 | 6 | d5f183263cec9922d23cfd38ce9157eef4e58edb | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 113 | 204 | 6 | 177414e4c859b047a4644664c596a3c22199cdf2 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 113 | 204 | 6 | 1df80af2c690dac6bfd3dfd7d0052b66c1ae6ea5 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 113 | 204 | 6 | 4b5f545dc02364c5d96a02b0acd68faf1ec4192b | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 113 | 204 | 6 | 927d1071f0719b778f0c3d358c5f96a6ffac6645 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 170 | 204 | 7 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.42e-05 | 171 | 204 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 171 | 204 | 7 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 116 | 204 | 6 | 15d9a3d8c3cc1f6a1aead03cf84dc876c76b7063 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 116 | 204 | 6 | e93dd059d272e597a30e93f4c0504636f4e6c899 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 116 | 204 | 6 | 27201cb805fe73b5ec51d7d585d047a4c043e8b0 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 116 | 204 | 6 | d3194bda2e3d5fd021e4015eed98c5888befe03d | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 116 | 204 | 6 | 4e84b6f6661bb5ba0fe0de38a23bee9cc3727d94 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-05 | 175 | 204 | 7 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 175 | 204 | 7 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 1.71e-05 | 176 | 204 | 7 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.78e-05 | 177 | 204 | 7 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | mild-Lymphocytic-B_cells_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.84e-05 | 178 | 204 | 7 | c6fb21401ad802a57e4e4f5a1723c42779fdb33e | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.84e-05 | 178 | 204 | 7 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 179 | 204 | 7 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.98e-05 | 180 | 204 | 7 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|metastatic_Brain / Location, Cell class and cell subclass | 1.98e-05 | 180 | 204 | 7 | 7de1c8ab1152fa517c6b4830d93ff53a19fca3d7 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.12e-05 | 182 | 204 | 7 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 183 | 204 | 7 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-05 | 183 | 204 | 7 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 183 | 204 | 7 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CXCL9+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 183 | 204 | 7 | 99a36e9c74346b619b3b87d8d6bbf9b4b797c821 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.20e-05 | 183 | 204 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.28e-05 | 184 | 204 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.36e-05 | 185 | 204 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-05 | 185 | 204 | 7 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 2.36e-05 | 185 | 204 | 7 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 186 | 204 | 7 | 5916ee851c17d6d9adefeea900b4dfa9642982dc | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 186 | 204 | 7 | fc6e591089c87a66653c8e552be9c0fe0c82ecd5 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.44e-05 | 186 | 204 | 7 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 186 | 204 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.44e-05 | 186 | 204 | 7 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| Drug | D-pantothenoyl-L-cysteine | 2.69e-06 | 4 | 201 | 3 | CID000440217 | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 6.42e-05 | 196 | 201 | 9 | 6647_UP | |
| Drug | V11294 Analogue 5f | 7.76e-05 | 2 | 201 | 2 | CID011214587 | |
| Drug | V11294 Analogue 5t | 7.76e-05 | 2 | 201 | 2 | CID011226695 | |
| Drug | V11294 Analogue 5e | 7.76e-05 | 2 | 201 | 2 | CID011443441 | |
| Drug | V11294 Analogue 5n | 7.76e-05 | 2 | 201 | 2 | CID011238279 | |
| Drug | V11294 Analogue 5p | 7.76e-05 | 2 | 201 | 2 | CID011478659 | |
| Drug | V11294 Analogue 5o | 7.76e-05 | 2 | 201 | 2 | CID011249748 | |
| Drug | V11294 Analogue 5c | 7.76e-05 | 2 | 201 | 2 | CID011179896 | |
| Drug | V11294 Analogue 5b | 7.76e-05 | 2 | 201 | 2 | CID011443760 | |
| Drug | Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid | 7.76e-05 | 2 | 201 | 2 | DB03849 | |
| Drug | T-2585.HCl | 7.76e-05 | 2 | 201 | 2 | CID006918355 | |
| Drug | V11294 Analogue 5m | 7.76e-05 | 2 | 201 | 2 | CID011477773 | |
| Drug | CHEMBL83995 | 7.76e-05 | 2 | 201 | 2 | CID009571169 | |
| Drug | V11294 Analogue 8a | 7.76e-05 | 2 | 201 | 2 | CID011442865 | |
| Drug | V11294 Analogue 5q | 7.76e-05 | 2 | 201 | 2 | CID011318772 | |
| Drug | V11294 Analogue 5h | 7.76e-05 | 2 | 201 | 2 | CID011306698 | |
| Drug | 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | 7.76e-05 | 2 | 201 | 2 | DB01959 | |
| Drug | 4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone | 7.76e-05 | 2 | 201 | 2 | DB01954 | |
| Drug | M 98 | 7.76e-05 | 2 | 201 | 2 | CID006420180 | |
| Drug | V11294 Analogue 5i | 7.76e-05 | 2 | 201 | 2 | CID011376249 | |
| Drug | V11294 Analogue 5d | 7.76e-05 | 2 | 201 | 2 | CID011283750 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzoic acid | 7.76e-05 | 2 | 201 | 2 | CID002779323 | |
| Drug | V11294 Analogue 5v | 7.76e-05 | 2 | 201 | 2 | CID011375325 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzaldehyde | 7.76e-05 | 2 | 201 | 2 | CID002735893 | |
| Drug | diethyl acetylenedicarboxylate | 7.76e-05 | 2 | 201 | 2 | CID000069803 | |
| Drug | Np-V | 7.76e-05 | 2 | 201 | 2 | CID009999276 | |
| Drug | (S)-Rolipram | 7.76e-05 | 2 | 201 | 2 | DB03606 | |
| Drug | 1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester | 7.76e-05 | 2 | 201 | 2 | ctd:C554440 | |
| Drug | V11294 Analogue 5r | 7.76e-05 | 2 | 201 | 2 | CID011168555 | |
| Drug | V11294 Analogue 5j | 7.76e-05 | 2 | 201 | 2 | CID011433797 | |
| Drug | V11294 Analogue 5a | 7.76e-05 | 2 | 201 | 2 | CID011386897 | |
| Drug | V11294 Analogue 5k | 7.76e-05 | 2 | 201 | 2 | CID011456440 | |
| Drug | (R)-Rolipram | 7.76e-05 | 2 | 201 | 2 | DB04149 | |
| Drug | plakin | 8.81e-05 | 82 | 201 | 6 | CID000018752 | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 1.22e-06 | 4 | 200 | 3 | DOID:3981 (implicated_via_orthology) | |
| Disease | cognitive function measurement | GALNT15 LVRN USP34 SYNPO2 PDE4D PPP2R2D PSMD2 GCNT4 FAM120A TBC1D1 RNF216 EFL1 ANKFY1 VPS8 THSD7B GRM8 RGS3 CEMIP LRIG3 FARP1 SETBP1 MYH15 TNKS KDM4B MYBPC3 | 1.50e-05 | 1434 | 200 | 25 | EFO_0008354 |
| Disease | unipolar depression, bipolar disorder | 9.83e-05 | 156 | 200 | 7 | EFO_0003761, MONDO_0004985 | |
| Disease | T-cell acute lymphoblastic leukemia (implicated_via_orthology) | 1.37e-04 | 3 | 200 | 2 | DOID:5603 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | STRBP INPP5K FABP7 SYNJ2 OTOGL DIO3 DNAH9 NOTCH3 NLRP8 TANK NRCAM SYNE1 RUFY1 FARP1 SETBP1 DIP2C MACF1 DOP1A SORL1 | 1.40e-04 | 1074 | 200 | 19 | C0006142 |
| Disease | platelet component distribution width | ARMC3 SPTA1 PSMD2 JMY DLC1 SYNJ2 VAV2 TFEC TANK SLC16A9 SYNE1 DNM1L CCND3 MACF1 EIF2AK4 | 2.13e-04 | 755 | 200 | 15 | EFO_0007984 |
| Disease | autistic disorder (implicated_via_orthology) | 2.72e-04 | 4 | 200 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | JAKMIP2 DLC1 NLRP8 TFEC NRCAM TCN2 SYNE1 CINP PEX5L SETBP1 TPX2 DIP2C SPAG17 SORL1 | 3.33e-04 | 702 | 200 | 14 | C0009402 |
| Disease | Autistic Disorder | 4.31e-04 | 261 | 200 | 8 | C0004352 | |
| Disease | colorectal health | 4.63e-04 | 201 | 200 | 7 | EFO_0008460 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 5.29e-04 | 97 | 200 | 5 | EFO_0007878, EFO_0009458 | |
| Disease | feeling emotionally hurt measurement | 5.71e-04 | 56 | 200 | 4 | EFO_0009599 | |
| Disease | neurotic disorder | 6.36e-04 | 101 | 200 | 5 | EFO_0004257 | |
| Disease | Calcium channel blocker use measurement | 6.53e-04 | 213 | 200 | 7 | EFO_0009930 | |
| Disease | alcohol use disorder measurement | 6.71e-04 | 214 | 200 | 7 | EFO_0009458 | |
| Disease | retinitis pigmentosa | 6.74e-04 | 6 | 200 | 2 | MONDO_0019200 | |
| Disease | pappalysin-1 measurement | 6.74e-04 | 6 | 200 | 2 | EFO_0802845 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 6.74e-04 | 6 | 200 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | Cystic kidney | 6.74e-04 | 6 | 200 | 2 | C0022679 | |
| Disease | diastolic blood pressure, systolic blood pressure | PDE4D HLA-DPA1 GCK DLC1 TBC1D1 SLX4IP EFL1 ANKFY1 CEMIP LRIG3 GDF7 FARP1 SETBP1 | 6.99e-04 | 670 | 200 | 13 | EFO_0006335, EFO_0006336 |
| Disease | phosphatidylcholine measurement | 7.50e-04 | 284 | 200 | 8 | EFO_0010226 | |
| Disease | response to quetiapine | 8.87e-04 | 28 | 200 | 3 | GO_0097335 | |
| Disease | heart rate | 9.00e-04 | 225 | 200 | 7 | EFO_0004326 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 9.39e-04 | 7 | 200 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | forced expiratory volume, response to bronchodilator | 9.74e-04 | 445 | 200 | 10 | EFO_0004314, GO_0097366 | |
| Disease | uric acid measurement | USP34 ACVR2A NSD3 QSOX2 FAT4 DNAJC13 SLC16A9 CEMIP SBF2 SETBP1 DIP2C KDM4B | 9.93e-04 | 610 | 200 | 12 | EFO_0004761 |
| Disease | proteoglycan 3 measurement | 1.25e-03 | 8 | 200 | 2 | EFO_0802970 | |
| Disease | pulse pressure measurement | USP34 GCK NSD3 DLC1 FES SLX4IP IFT80 QSOX2 NOTCH3 TBX2 DIP2B NPR3 B3GLCT ATG7 LRIG3 GDF7 SBF2 EIF2AK4 KDM4B MYBPC3 | 1.31e-03 | 1392 | 200 | 20 | EFO_0005763 |
| Disease | pulse pressure measurement, alcohol drinking | 1.32e-03 | 70 | 200 | 4 | EFO_0004329, EFO_0005763 | |
| Disease | sugar consumption measurement | 1.38e-03 | 120 | 200 | 5 | EFO_0010158 | |
| Disease | heel bone mineral density, urate measurement | 1.56e-03 | 182 | 200 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 1.57e-03 | 34 | 200 | 3 | DOID:9952 (is_marker_for) | |
| Disease | age-related hearing impairment | 1.73e-03 | 324 | 200 | 8 | EFO_0005782 | |
| Disease | systolic blood pressure, alcohol drinking | 1.84e-03 | 128 | 200 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | C-C motif chemokine 21 measurement | 1.98e-03 | 10 | 200 | 2 | EFO_0008048 | |
| Disease | thrombin generation potential measurement | 2.42e-03 | 11 | 200 | 2 | EFO_0005538 | |
| Disease | Cystic Kidney Diseases | 2.42e-03 | 11 | 200 | 2 | C1691228 | |
| Disease | Abruptio Placentae | 2.89e-03 | 12 | 200 | 2 | EFO_1001754 | |
| Disease | rectum cancer | 2.90e-03 | 42 | 200 | 3 | EFO_1000657 | |
| Disease | autistic disorder (is_implicated_in) | 2.90e-03 | 42 | 200 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 2.90e-03 | 42 | 200 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | fatty acid measurement | 3.06e-03 | 436 | 200 | 9 | EFO_0005110 | |
| Disease | amyotrophic lateral sclerosis | 3.15e-03 | 145 | 200 | 5 | MONDO_0004976 | |
| Disease | ornithine measurement | 3.31e-03 | 44 | 200 | 3 | EFO_0009776 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 3.39e-03 | 13 | 200 | 2 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 3.39e-03 | 13 | 200 | 2 | C0002514 | |
| Disease | insomnia measurement | 3.40e-03 | 443 | 200 | 9 | EFO_0007876 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.53e-03 | 45 | 200 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 3.74e-03 | 93 | 200 | 4 | C1535926 | |
| Disease | neuroticism measurement | DLGAP2 HLA-DPA1 ACVR2A FAM120A NTN1 GALNT10 GRM8 FARP1 ASXL3 SCARB1 SBF2 DIP2C TNKS AURKB | 3.78e-03 | 909 | 200 | 14 | EFO_0007660 |
| Disease | inositol measurement | 3.94e-03 | 14 | 200 | 2 | EFO_0010504 | |
| Disease | Impaired cognition | 3.94e-03 | 14 | 200 | 2 | C0338656 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 3.94e-03 | 14 | 200 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | Squamous cell carcinoma of esophagus | 4.03e-03 | 95 | 200 | 4 | C0279626 | |
| Disease | small vessel stroke | 4.19e-03 | 96 | 200 | 4 | EFO_1001504 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 4.42e-03 | 157 | 200 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Down syndrome (implicated_via_orthology) | 4.53e-03 | 15 | 200 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | cryptococcosis | 4.53e-03 | 15 | 200 | 2 | EFO_0007229 | |
| Disease | age at menopause | 4.69e-03 | 302 | 200 | 7 | EFO_0004704 | |
| Disease | spontaneous preterm birth | 5.01e-03 | 101 | 200 | 4 | EFO_0006917 | |
| Disease | epilepsy (implicated_via_orthology) | 5.17e-03 | 163 | 200 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Weight Gain | 5.19e-03 | 102 | 200 | 4 | C0043094 | |
| Disease | TPE interval measurement | 5.31e-03 | 52 | 200 | 3 | EFO_0004644 | |
| Disease | neuroticism measurement, cognitive function measurement | ACVR2A FAM120A GALNT10 B3GLCT TANK THSD7B GRM8 FARP1 ASXL3 AURKB | 5.48e-03 | 566 | 200 | 10 | EFO_0007660, EFO_0008354 |
| Disease | thyroxine measurement, triiodothyronine measurement | 5.81e-03 | 17 | 200 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.81e-03 | 17 | 200 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | QRS-T angle | 5.94e-03 | 106 | 200 | 4 | EFO_0020097 | |
| Disease | Oral ulcer | 6.14e-03 | 107 | 200 | 4 | HP_0000155 | |
| Disease | anxiety measurement | 6.34e-03 | 108 | 200 | 4 | EFO_0009863 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELQKLEVGIHTKAWF | 36 | Q9NVA4 | |
| KKESIKDGHWDINFE | 111 | Q86Y25 | |
| WFEIHVGSKEGDLLN | 91 | Q14264 | |
| KLWKNEKEERFAFGH | 2706 | Q9NR48 | |
| DLHDILDYWKGVSAQ | 811 | P0C7U0 | |
| GKLKWDLAAVIAHDF | 146 | P30281 | |
| EDFWKVKEFLHNQGK | 586 | Q9H4A4 | |
| DLKHEIALYIWDKGG | 216 | Q6Y288 | |
| KDNKAQDWEKHFLDA | 221 | Q96L12 | |
| EAEEWGKFLHTKNKL | 86 | O00429 | |
| FDDGEHAKQKSVISW | 966 | Q9P2K8 | |
| LKDGAENDLTWVLKH | 1026 | Q96NH3 | |
| HDKKAFLNDSEWELL | 196 | O95264 | |
| VDLWLITAFHEKGSL | 261 | P27037 | |
| TQEKIWEFKGKLEQH | 796 | Q7Z2Z2 | |
| DNHLGKFKLDNDTGW | 3026 | Q6V0I7 | |
| LKIHLKDWEGNEAYS | 371 | O15123 | |
| DLDKKETVWHLEEFG | 66 | P20036 | |
| VDSLDFNKKILHTAW | 416 | Q66LE6 | |
| DGSWFLKLLHAETKR | 866 | Q9P1A6 | |
| FKHVALTLWDQLGDG | 871 | Q5JWR5 | |
| NKDLVFSTWDHKAKG | 376 | Q9Y5C1 | |
| KEKLPDFSWELHISE | 761 | Q5W041 | |
| QLSKELFAKWVDHPE | 801 | Q6Q4G3 | |
| WEELGVKEAQLKAHI | 76 | Q96M95 | |
| SKLVLWDINKHGLEE | 61 | Q8NBQ5 | |
| WDEDSGLLFLKLKAQ | 1131 | Q8WUJ3 | |
| SGLGHLKWTKAEDID | 236 | Q9C0F0 | |
| WEDFHQKLVDGSLLT | 106 | P49418 | |
| SWKRGDKHDFEAKQA | 301 | P17342 | |
| WLEHIAKGKTSEALA | 796 | Q04656 | |
| LAEVAKKAYGWLHED | 426 | Q9ULI1 | |
| AVQIHILKADKAGDW | 496 | O95631 | |
| DWFDGKEFHGNIIKV | 301 | Q92804 | |
| LASWDEGHVLTFLKQ | 546 | Q6ZRP7 | |
| FAKQLDEWLKVALHD | 286 | Q33E94 | |
| EALKWGESLEKLLVH | 1066 | P49796 | |
| IWKGHLDALTADVKE | 801 | P57740 | |
| HEDIDKGILLNWTKG | 156 | P35557 | |
| EWKEFFSQGIHSLLL | 1306 | O94822 | |
| ESQLWREKKFGLIDH | 681 | Q6NSI4 | |
| HFKLDLDVAGLKNWV | 521 | O75106 | |
| LKDHEGSTALWLAVQ | 396 | Q9P2R3 | |
| KQWLEALGGKEALSH | 361 | A1A4S6 | |
| TGKLKTDNVFWGEHF | 246 | Q5VWQ8 | |
| KKKWNLEISLDSGHE | 226 | Q92637 | |
| TLANGDWKQDSLLHK | 241 | Q7RTY1 | |
| GKFVESKSDKWIDIH | 46 | Q02252 | |
| KGQDSHWVEDKQLFI | 536 | Q96AA8 | |
| LAALKAGHWVVLDEL | 1811 | Q9NU22 | |
| WKSKDILVDLGHLEG | 121 | Q9NPA3 | |
| LGKFFQEGWLKVDDH | 2516 | Q5T1H1 | |
| KHKFVFIVAWNEIEG | 26 | Q8N9B5 | |
| KALTLDQWLEQHKGD | 281 | Q9HBL8 | |
| IEWFKGAKGSALHED | 486 | Q92823 | |
| ATWHGDDFKDKLNLK | 566 | Q8NI17 | |
| VLIEKDWISFGHKFS | 366 | Q9Y217 | |
| LVEKEWLSFGHKFSQ | 1441 | Q86WG5 | |
| ENALKDEGAKHIWNA | 876 | Q86W28 | |
| TFAWKKDNELLHDAE | 531 | Q6UXM1 | |
| LASLKAVWHGQKLDF | 111 | P55073 | |
| KTFFLGDGQKLKDWH | 61 | Q86SR1 | |
| GDGQKLKDWHDKEAI | 66 | Q86SR1 | |
| KLDEVFSKISWLGIH | 336 | Q58FF6 | |
| WNGSFLEKKIDEHFK | 436 | Q15034 | |
| TDKSEIFVHGDLKWD | 4541 | Q2LD37 | |
| GWDNDKKIGILHENF | 326 | Q9Y6G9 | |
| KDLQRGVLDWKLDFH | 326 | Q8N3T1 | |
| KAKLDNLDEEWATEH | 61 | Q5SWX8 | |
| DHLAKELEDLNKWGL | 336 | Q07343 | |
| KELEDVNKWGLHVFR | 396 | Q08499 | |
| QTQLEKWDDVKFHGD | 171 | Q8IYB4 | |
| LDLKGEFIWVDGSHV | 226 | P06734 | |
| DVNAVDELGKSALHW | 1931 | Q9UM47 | |
| VNVLDFKKDAGLWHG | 556 | Q9P265 | |
| ALHWLADLATQKAKE | 1221 | Q7LBC6 | |
| ELWKQGKDLTVLDHT | 331 | O94953 | |
| ELKHLWENLGEKIAH | 2326 | O94854 | |
| GHNLYLEEKKQVEWD | 446 | Q96PP9 | |
| FNGALEKARLHEWVK | 96 | Q9NZB2 | |
| LQDLAAKKESVAHWE | 801 | Q9Y5S2 | |
| AAKTEWLDGKHVAFG | 116 | P0DN26 | |
| LEAAKKLNQSGHFLW | 291 | O00222 | |
| KHWEAELATLKGNNA | 181 | Q86YM7 | |
| IEHLKSLLDDWASKG | 4366 | Q9UPN3 | |
| WHFLLGDKASKRLTE | 41 | O95299 | |
| AAKTEWLDGKHVAFG | 116 | A0A075B759 | |
| KANHKVVFAADGILW | 131 | O00469 | |
| HLKDWFLENKSEVPE | 111 | Q96IZ6 | |
| WSKGQLKALFLEHEG | 341 | Q9H999 | |
| QEFFDHVKKLWDDEG | 131 | P38405 | |
| WSKGQLKALFSEHEG | 541 | Q9BZ23 | |
| AAKTEWLDGKHVAFG | 116 | F5H284 | |
| KLGKEVLATLEGHWD | 626 | Q9BZF1 | |
| AAFEKWGTLHETQKF | 221 | Q6GPH6 | |
| AAKTEWLDGKHVAFG | 116 | Q9Y536 | |
| LAAGKKWGHEAIEAN | 336 | Q9ULW2 | |
| NLRVFEDESGKHWSK | 51 | Q8TEA8 | |
| IVKVFHGADSDIEWL | 361 | Q01780 | |
| KWSDLEDHDGLVFVK | 21 | Q8IU89 | |
| LHYAEGLQIDWEKIK | 736 | Q9P2H3 | |
| WTHLTEFELKGLKAL | 506 | Q8NHM5 | |
| ALDVGFWHELTQKKL | 21 | O95352 | |
| EDQDKLTHLKDLIAW | 1561 | Q92608 | |
| LIKDGHWFANKFDSK | 401 | Q9P109 | |
| IHDTADWKDLNLKFV | 611 | Q9HCG7 | |
| LWKHSEALEALENGI | 641 | Q9Y4F1 | |
| GLWEKDQLSIAKKHD | 216 | Q9BT40 | |
| EKALGTWKRHAEELN | 341 | Q6ZRK6 | |
| HRLEEKKTWLTNGFD | 456 | Q92828 | |
| DLKDAHLTWEVAGKV | 196 | P01880 | |
| IHKFNNLIKLEESGW | 521 | Q15398 | |
| IVNVLDFKKDVGLWH | 536 | Q9Y2E4 | |
| WSAFKDQKHDLFISE | 2186 | O75165 | |
| KKWDLEISLDSGHEK | 321 | P12314 | |
| EFWLGNDKIHLLTKS | 281 | Q14314 | |
| LIRGWDDLFNKVKEH | 1486 | Q14204 | |
| EKVDLTQFKWIHIEG | 126 | P50053 | |
| VAEAALDLAAKKGHW | 3941 | Q9NYC9 | |
| SEKVLQGKNHWVIDF | 681 | Q8IXB1 | |
| SLDGDKLVHIQKWDG | 86 | O15540 | |
| LFSEDFKIHDPEAKW | 136 | P42658 | |
| SLWKELSLQHEGLKE | 411 | Q68D06 | |
| EEAANGKKSHWAELE | 21 | Q9ULM6 | |
| LKKLVEQHGTDDWTL | 46 | P10243 | |
| NKWLIEKEGEFTLHG | 156 | Q8WV22 | |
| FHDAINWGESKIKGS | 66 | Q3ZCN5 | |
| KIRSQEKYNDGLWHD | 1541 | Q16363 | |
| WSKGQLKALFLEHEG | 566 | Q8TE04 | |
| KFDFLLAWHKTGSEE | 176 | O75818 | |
| KDKWVLNHEDLVLGE | 551 | P07332 | |
| WVSGHLTDKDLLAFL | 191 | Q5VVY1 | |
| ADFRKDSKNLGDQWH | 196 | P49247 | |
| HISKKWGFTKFNADE | 166 | Q96L21 | |
| LGFAEAFLEHLWKKL | 376 | Q9NYV6 | |
| AFLEHLWKKLQDPSN | 381 | Q9NYV6 | |
| VKNVHDLLAKLAWDF | 446 | Q93008 | |
| NDHVLLFWKSLALKE | 2036 | Q92673 | |
| ALQGLVWLKDKEATH | 531 | Q8WXA3 | |
| KDQEDLKWAFSKHET | 2116 | Q8NF91 | |
| QLKLHWEDFDVFTKG | 356 | O15056 | |
| KFKLLDGSQWNEEHL | 476 | Q8NE09 | |
| HISKKWGFTKFNADE | 166 | P27635 | |
| LTDDGNKWLYKNKDH | 391 | Q13200 | |
| SGKALADWKQKHEES | 1461 | Q9Y2K3 | |
| NQALKGHAWLKDDEA | 631 | Q96T51 | |
| RKPLHVDFKELGWDD | 351 | Q7Z4P5 | |
| VDNKEALWKFLLSGA | 86 | Q8N5S1 | |
| IHLVDKWNGLSKVDF | 231 | Q8WTV0 | |
| GNIEKTFWDLKEEFH | 136 | Q92844 | |
| ALKHVSDWLDETNKG | 41 | Q96SI9 | |
| DGHAWDIGDVQKLLS | 491 | Q8WX94 | |
| DFKVLSSQDIKWALH | 381 | Q9NWF9 | |
| GFTHDELLKVWKGLF | 46 | P56182 | |
| ALALAWSFHEGKAKA | 516 | Q8N3P4 | |
| LKEQHLWDVDLLDSK | 1386 | Q96QB1 | |
| FILEGSLKAWKEEQH | 931 | Q6Q759 | |
| QAKDSIKAAESHWGL | 221 | Q5VYV7 | |
| EGFLNRKHEWEAHNK | 2201 | Q01082 | |
| HGEVLEWQKTFEEKL | 656 | Q9BXP5 | |
| LKWFLEDEKRAIGHD | 131 | P20062 | |
| HNLILKWETLNDAGF | 31 | Q9BW66 | |
| KDSNKEFWLLGHAEI | 76 | Q8TAZ6 | |
| DDKHDWDQRANALKK | 101 | O75122 | |
| EEVANGKKSHWAELE | 26 | Q96LI5 | |
| KGELKIADFGWSVHA | 211 | Q96GD4 | |
| AFKDEVLNHWLKEKS | 901 | P48736 | |
| WEDSLKDGHQLKQLL | 2251 | Q96JI7 | |
| AEAVKKDRLDFHQGW | 501 | Q9H4L4 | |
| ATKTKNGWANELLHE | 381 | A0JNW5 | |
| WIGKHANEEEKKAAA | 661 | P09327 | |
| TFLDKKDWTGNELHE | 36 | A8K554 | |
| QKHLHDLEFQWKDGE | 91 | Q08AN1 | |
| VKWGESFDKLLSHRD | 81 | Q9NS28 | |
| NFDWDSGLVDIEKKL | 461 | Q9UMS6 | |
| GDWKNHFTVALNEKF | 261 | P49888 | |
| KVTLEAKELWDQFHK | 106 | Q13207 | |
| LHLHKEDGWAQETLL | 131 | A6NE52 | |
| NEFHVKIADFGLSKW | 156 | O43353 | |
| HWKIDDKKFGLTFQS | 91 | Q7Z699 | |
| ADEKLEKFWIDFNLG | 311 | Q5T4T6 | |
| ALEHLEKEVLEFWGK | 776 | Q5T4T6 | |
| ADLWKFTPLHEAAAK | 746 | O95271 | |
| KEWGLLDEAQKCLYH | 26 | Q9Y2P7 | |
| EIIKWAGFHTIKDDI | 331 | Q8IX01 | |
| RGEIWKFLAEQFHLK | 806 | Q86TI0 | |
| ASLLGKNWEEHSVKD | 81 | Q9HAH1 | |
| GHKWEKNLALSRELD | 3126 | Q6ZS81 | |
| HEKLRGWLKSNVSDA | 186 | P60174 | |
| HAADKQLFTLVEWAK | 271 | P48443 | |
| KEHWDHLLERTNDKG | 1586 | P02549 | |
| QFVEHWEKLKELAKA | 1796 | P02549 | |
| QLAVDWFLDKGHKDI | 216 | Q5HYM0 | |
| AQWDIGIAHAEKALK | 366 | Q9BZ95 | |
| KESHGINNFDLKEVW | 86 | Q86XU0 | |
| KLLAIGKEDDNAQWH | 46 | O14948 | |
| KLAVDWFLERGHKDI | 271 | Q9C0D7 | |
| DGFNWKELLKIKSAH | 1421 | Q70CQ2 | |
| SLADSDHLQDWLKKL | 1646 | Q70CQ2 | |
| DNWIHITEAKKFDSL | 726 | P52735 | |
| KDKDELDHLALEWQI | 316 | Q9BXT5 | |
| AAHLEGKKDNQFIWK | 31 | Q9C0I4 | |
| VKHIAWLAEQAKLDG | 326 | Q13425 | |
| LSDAQHWTQAKEKGD | 1236 | Q9Y6X0 | |
| KDFDWNLKHGRVFII | 401 | Q9Y5A9 | |
| KLLSAGEDTFVHIWK | 266 | Q9H977 | |
| GALKAQTWKHQLEEE | 601 | Q9ULW0 | |
| HKLVDDWTKEAVGNS | 1651 | Q9BYP7 | |
| FHPKALAELTKSDWE | 26 | P57678 | |
| FTGKCIFLEWDHVEK | 256 | O95970 | |
| HDDWQIGKTKIFLKD | 716 | Q13402 | |
| ELADHDAEVKWLKNG | 386 | Q14896 |